Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Syndax Pharmaceuticals

Clinical trials sponsored by Syndax Pharmaceuticals, explained in plain language.

Syndax Pharmaceuticals SNDX NASDAQ

A biopharmaceutical company developing cancer therapies, including treatments for leukemia and other malignancies.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 3 Not yet finished but already full! 3 Completed 1 Terminated 1

New hope for tough cancers: revumenib trial shows promise

Disease control Terminated

This early-stage study tested the drug revumenib in 42 adults with colorectal cancer or other solid tumors that had spread or come back after at least one prior treatment. The goal was to see if the drug is safe and can slow tumor growth. Researchers measured side effects, how th…

Phase: PHASE1, PHASE2 • Sponsor: Syndax Pharmaceuticals • Aim: Disease control

Last updated Jul 08, 2026 00:00 UTC